Collagen Matrix, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Collagen Matrix, Inc.
US FDA released seven device-related close-out letters in November.
The device has 510(k) clearance for a broad tendon-repair indication, but the company is sponsoring clinical trials to further validate the technology, which induces new tissue growth around partially torn rotator cuffs rather than simply mechanically reattaching it.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
- Implantable Devices
Drug Discovery Tools
- Drug Discovery Tools